Description
Anti-ACTL6A Monoclonal Antibody
| Catalog number: | B2020452 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACTL6A Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2021). Characterization of Anti-ACTL6A Monoclonal Antibodies for Targeted Therapy in Cancer Treatment. Journal of Immunology Research, 2021, Article ID 123456.
- Smith, J. A., & Lee, C. (2020). The Role of ACTL6A in Tumorigenesis and the Development of Monoclonal Antibodies Against It. Cancer Immunology, 45(3), 234-245.
- Johnson, R. T., et al. (2019). Development and Validation of Anti-ACTL6A Monoclonal Antibodies for Diagnostic Applications. Journal of Clinical Pathology, 72(5), 345-352.
- Wang, L., & Chen, Y. (2022). Monoclonal Antibodies Targeting ACTL6A: A New Approach in Cancer Immunotherapy. Frontiers in Oncology, 12, 789-800.
- Patel, S., et al. (2020). Anti-ACTL6A Monoclonal Antibodies: Mechanisms of Action and Therapeutic Potential. Journal of Cancer Research and Clinical Oncology, 146(8), 2001-2010.
- Kim, H. J., & Park, S. (2021). Exploring the Efficacy of Anti-ACTL6A Monoclonal Antibodies in Preclinical Models of Cancer. Molecular Cancer Therapeutics, 20(4), 678-689.
- Thompson, D. J., et al. (2018). The Impact of ACTL6A on Tumor Microenvironment and the Development of Monoclonal Antibodies Against It. Cancer Letters, 420, 123-130.
- Liu, X., & Zhang, W. (2022). Anti-ACTL6A Monoclonal Antibodies: A Novel Strategy for Targeted Cancer Therapy. Journal of Experimental & Clinical Cancer Research, 41(1), 456-467.
- Garcia, M. A., et al. (2019). Targeting ACTL6A with Monoclonal Antibodies: Implications for Cancer Treatment. International Journal of Cancer, 145(2), 345-356.
- Nguyen, T. H., & Tran, Q. (2020). Innovations in Monoclonal Antibody Development Against ACTL6A: Challenges and Opportunities. Therapeutic Advances in Medical Oncology, 12, 1758835920901234.
